- Report
- November 2025
- 150 Pages
Global
From €4390EUR$4,850USD£3,761GBP
- Report
- November 2025
- 150 Pages
Global
From €4390EUR$4,850USD£3,761GBP
- Report
- November 2025
- 150 Pages
Global
From €4390EUR$4,850USD£3,761GBP
- Report
- September 2025
- 150 Pages
Global
From €4390EUR$4,850USD£3,761GBP
- Report
- August 2025
- 150 Pages
Global
From €4390EUR$4,850USD£3,761GBP
- Report
- July 2025
- 150 Pages
Global
From €4390EUR$4,850USD£3,761GBP
- Report
- September 2025
- 150 Pages
Global
From €4028EUR$4,450USD£3,451GBP
- Report
- March 2026
- 157 Pages
Global
From €3500EUR$4,142USD£3,103GBP
- Training
- October 2026
- 2 Days
Global
€1569EUR$1,794USD£1,299GBP
€1811EUR$2,071USD£1,499GBP
- Report
- May 2026
- 140 Pages
Global
From €4390EUR$4,850USD£3,761GBP
- Report
- December 2025
- 250 Pages
Global
From €4390EUR$4,850USD£3,761GBP
- Report
- October 2025
- 87 Pages
Global
From €4390EUR$4,850USD£3,761GBP
- Report
- September 2025
- 250 Pages
Global
From €4390EUR$4,850USD£3,761GBP
- Report
- August 2025
- 200 Pages
United States
From €2254EUR$2,490USD£1,931GBP
- Report
- May 2026
- 150 Pages
United States
From €4390EUR$4,850USD£3,761GBP
- Report
- March 2026
- 248 Pages
United States
From €4390EUR$4,850USD£3,761GBP
- Report
- December 2022
- 354 Pages
Global
From €4772EUR$5,456USD£3,950GBP
- Report
- October 2018
- 450 Pages
Global
From €3167EUR$3,499USD£2,713GBP
- Report
- February 2025
- 120 Pages
Global
From €5386EUR$5,950USD£4,614GBP
- Report
- August 2024
- 70 Pages
United States
From €4481EUR$4,950USD£3,839GBP

The Inhalers and Nebulisers market is a segment of the medical device industry that focuses on the development and production of devices used to deliver medication to the lungs. Inhalers and nebulisers are used to treat a variety of respiratory conditions, including asthma, COPD, and cystic fibrosis. Inhalers are handheld devices that deliver medication directly to the lungs in the form of a mist or aerosol. Nebulisers are larger devices that use a compressor to convert liquid medication into a mist that can be inhaled.
Inhalers and nebulisers are used by millions of people around the world, and the market is expected to grow in the coming years. Companies in the market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, and Teva Pharmaceuticals. These companies are involved in the development and production of inhalers and nebulisers, as well as the research and development of new treatments for respiratory conditions. Show Less Read more